Filing Flows › Inovio Pharmaceuticals (INO) › Recalls, complaints & regulation
Inovio Pharmaceuticals (INO): clinical trials
Inovio Pharmaceuticals (INO) beyond its filings: 1 active clinical trial.
Inovio Pharmaceuticals' latest quarter
Inovio Pharmaceuticals, Q1 2025: revenue $65K, net loss $19.7M, operating cash flow −$26.9M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Inovio Pharmaceuticals have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.